The director of Italy's medicines regulatory agency has been suspended along with another top official, as the drug licences-for-cash scandal surrounding the organisation continues to unfold. Nello Martini, director of Aifa (the Italian Agency for Pharmaceuticals), has been suspended along with Caterina Gualano, head of medicines registration for the agency. The development follows a two-year investigation in which police found evidence that money had changed hands in return for the falsification of clinical data required for drug licences.
Read article at pharmatimes.com
Thursday, July 03, 2008
Drug licences for cash scandal unfolds in Italy
Posted by
Willow
at
11:44 am
Labels: Aifa, Caterina Gualano, corporate corruption of science, corruption, drug company profits, drug licences, Nello Martini, prescription drugs
Thursday, May 29, 2008
Bayer & Glaxo Linked To Bribes In Italy
A drug licences-for-cash scandal has engulfed Italy's medicines regulatory agency with leading officials arrested along with people linked to major drugmakers, PharmaTimes writes. The most senior figure to have been held is Pasqualino Rossi, vp of Aifa, the Italian Agency for Pharmaceuticals, and one of Italy's most senior reps at the European Medicines Agency. Five lobbyists have also been arrested, and an eighth person is being sought. Arrest warrants were issued after an investigating judge saw a 400-word police report suggesting money had changed hands in return for falsifying clinical data required for drug licences, according to PharmaTimes.
Read article at pharmalot.com
Posted by
Willow
at
9:39 pm
Labels: Aifa, Bayer, drug companies, European Medicines Agency, Glaxo, Pasqualino Rossi

